Signal Opportunity · Strategic initiative
Surgo Health Launches Derin to Sell AI-Moderated Patient Research to Healthcare Buyers
- Location
- US
- Industry
- Health tech
- Employees
- Not stated
- Opportunity type
- Strategic initiative
What happened
On November 17, 2026, Surgo Health, a Public Benefit Corporation, launched Derin, an AI research platform built specifically for healthcare. Derin runs open-ended, AI-moderated conversations instead of fixed-response surveys, combining qualitative depth with quantitative scale to explain why patients make the health decisions they do.
The launch is anchored by an early adopter, Upstream USA, a national nonprofit whose healthcare partners reach about 1.5 million patients a year across 37 states and Washington, D.C. Upstream used Derin to study attitudes and trade-offs around contraceptive care amid open enrollment, rising premiums and new Medicaid rules. Surgo positions Derin for health systems, payers, nonprofits and pharmaceutical companies, and cites partners including the Gates Foundation, J&J, Takeda, Pivotal Ventures and the Clinton Health Access Initiative, along with more than 40 peer-reviewed publications.
Relevant services
- PR & communications
- Digital marketing
- Content & video
- Research & strategy
Overview
Surgo Health is a Public Benefit Corporation that builds AI-powered data products to reveal the beliefs, barriers and behaviors that drive health outcomes. Its tools help healthcare organizations improve clinical trial design, care delivery and public health strategy. Customers and partners span pharmaceutical companies, payers, health systems, nonprofits and global health funders. Its newest product, Derin, is a research platform that blends qualitative and quantitative methods through AI-moderated conversations.
Why this could be interesting
- A new B2B platform launch needs awareness among healthcare buyers.
Best suited for: B2B healthcare tech marketing agency.
Summary by Agency Field Guide from public reporting. Nobody has asked for proposals; this is a reason to reach out, not an invitation to bid.